Mereo BioPharma (MREO) Operating Leases (2020 - 2024)
Historic Operating Leases for Mereo BioPharma (MREO) over the last 5 years, with Q4 2024 value amounting to $187000.0.
- Mereo BioPharma's Operating Leases fell 7935.98% to $187000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $187000.0, marking a year-over-year decrease of 7935.98%. This contributed to the annual value of $187000.0 for FY2024, which is 7935.98% down from last year.
- As of Q4 2024, Mereo BioPharma's Operating Leases stood at $187000.0, which was down 7935.98% from $394000.0 recorded in Q3 2024.
- Mereo BioPharma's 5-year Operating Leases high stood at $2.4 million for Q4 2021, and its period low was $187000.0 during Q4 2024.
- In the last 5 years, Mereo BioPharma's Operating Leases had a median value of $1.1 million in 2023 and averaged $1.1 million.
- In the last 5 years, Mereo BioPharma's Operating Leases soared by 5462.94% in 2021 and then tumbled by 7935.98% in 2024.
- Mereo BioPharma's Operating Leases (Quarter) stood at $1.5 million in 2020, then skyrocketed by 54.63% to $2.4 million in 2021, then plummeted by 37.45% to $1.5 million in 2022, then tumbled by 38.74% to $906000.0 in 2023, then crashed by 79.36% to $187000.0 in 2024.
- Its Operating Leases stands at $187000.0 for Q4 2024, versus $394000.0 for Q3 2024 and $552000.0 for Q2 2024.